The effect of various in vitro conditions on the permeability characteristics of the buccal mucosa

被引:76
作者
Nicolazzo, JA [1 ]
Reed, BL [1 ]
Finnin, BC [1 ]
机构
[1] Monash Univ, Dept Pharmaceut, Parkville, Vic 3052, Australia
关键词
buccal mucosa; permeability; caffeine; estradiol; paracellular; transcellular; tissue integrity; tissue viability;
D O I
10.1002/jps.10505
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The effect of various in vitro conditions on the permeability characteristics of the buccal mucosa was. assessed using caffeine (CAF) and estradiol (E-2) as model hydrophilic and lipophilic markers, respectively. The permeation of CAP and E-2 through porcine buccal mucosa was determined in modified Ussing chambers at 37degreesC over 4 h. Comparative permeation studies were performed through full thickness and epithelial tissues, fresh and frozen tissues, and intact and intentionally damaged tissues. Tissue integrity was monitored by the absorption of, the normally impermeable fluorescein isothiocyanate (FITC)-labeled dextran 20 kDa (FD20) and tissue viability wag assessed using an MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumum bromide) biochemical assay and histological evaluation. Compared to full thickness buccal tissue, permeability through the buccal epithelium was 1.8-fold greater for CAF and 16.7-fold greater for E-2. Although the fluxes of the model compounds were, no different in fresh and frozen buccal epithelium, histological evaluation demonstrated signs of cellular death in frozen tissue. FD20 permeated damaged tissue, and while this was associated with an increase in CAF transport, no significant change in E-2 transport was observed. The tissue appeared to remain viable for up to 12 h postmortem using the MTT viability assay, and this was supported by histological evaluation. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:2399 / 2410
页数:12
相关论文
共 36 条
[1]   Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium [J].
Agu, RU ;
Dang, HV ;
Jorissen, M ;
Willems, T ;
Kinget, R ;
Verbeke, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 237 (1-2) :179-191
[2]  
[Anonymous], PHARM TECHNOL
[3]  
[Anonymous], 1996, DRUGS PHARM SCI
[4]   The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds [J].
Aungst, BJ ;
Nguyen, NH ;
Bulgarelli, JP ;
Oates-Lenz, K .
PHARMACEUTICAL RESEARCH, 2000, 17 (10) :1175-1180
[5]   METHODS FOR INVITRO PERCUTANEOUS-ABSORPTION STUDIES .6. PREPARATION OF THE BARRIER LAYER [J].
BRONAUGH, RL ;
STEWART, RF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (05) :487-491
[6]   METHODS FOR INVITRO PERCUTANEOUS-ABSORPTION STUDIES .3. HYDROPHOBIC COMPOUNDS [J].
BRONAUGH, RL ;
STEWART, RF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (09) :1255-1258
[7]   Buccal transport of flecainide and sotalol:: effect of a bile salt and ionization state [J].
Deneer, VHM ;
Drese, GB ;
Roemelé, PEH ;
Verhoef, JC ;
Lie-A-Huen, L ;
Kingma, JH ;
Brouwers, JRBJ ;
Junginger, HE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 241 (01) :127-134
[8]  
DEVRIES ME, 1991, CRIT REV THER DRUG, V8, P271
[9]   LOCALIZATION OF THE PERMEABILITY BARRIER INSIDE PORCINE BUCCAL MUCOSA - A COMBINED INVITRO STUDY OF DRUG PERMEABILITY, ELECTRICAL-RESISTANCE AND TISSUE MORPHOLOGY [J].
DEVRIES, ME ;
BODDE, HE ;
VERHOEF, JC ;
PONEC, M ;
CRAANE, WIHM ;
JUNGINGER, HE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 76 (1-2) :25-35
[10]   MECHANISMS OF PENETRATION ENHANCEMENT FOR TRANSBUCCAL DELIVERY OF SALICYLIC-ACID [J].
GANDHI, R ;
ROBINSON, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 85 (1-3) :129-140